Genetic Polymorphisms of Drug-Metabolizing Enzymes Involved in 6-Mercaptopurine-Induced Myelosuppression in Thai Pediatric Acute Lymphoblastic Leukemia Patients

Abstract

Genetic polymorphisms of thiopurine S-methyltransferase (TPMT) and nucleoside diphosphate-linked moiety X-type motif 15 (NUDT15) genes have been proposed as key determinants of 6-mercaptopurine (6-MP)-induced myelosuppression in pediatric acute lymphoblastic leukemia (ALL). In the present study, genotypes of TPMT and NUDT15 were investigated in 178 Thai pediatric patients with ALL by the TaqMan SNP genotyping assay and DNA sequencing. The frequency of TPMT*3C was 0.034. Among NUDT15 variants, NUDT15*3 is the most common variant with the allele frequency of 0.073, whereas those of NUDT15*2, NUDT15*5, and NUDT15*6 variants were 0.022, 0.011, and 0.039. These data suggest that a high proportion of Thai pediatric ALL patients may be at risk of thiopurine-induced myelosuppression.

Keywords

thiopurine methyltransferase - nucleoside diphosphate-linked moiety X-type motif 15 - pediatric acute lymphoblastic leukemia

Publikationsverlauf

Eingereicht: 20. April 2020

Angenommen: 10. Juni 2020

Artikel online veröffentlicht:
08. September 2020

• References

• 1 Kato M, Manabe A. Treatment and biology of pediatric acute lymphoblastic leukemia. Pediatr Int (Roma) 2018; 60 (01) 4-12
• 2 Burchenal JH, Murphy ML, Ellison RR. et al. Clinical evaluation of a new antimetabolite, 6-mercaptopurine, in the treatment of leukemia and allied diseases. Blood 1953; 8 (11) 965-999
• 3 Coelho T, Andreoletti G, Ashton JJ. et al. Genes implicated in thiopurine-induced toxicity: comparing TPMT enzyme activity with clinical phenotype and exome data in a paediatric IBD cohort. Sci Rep 2016; 6: 34658
• 4 Moriyama T, Nishii R, Perez-Andreu V. et al. NUDT15 polymorphisms alter thiopurine metabolism and hematopoietic toxicity. Nat Genet 2016; 48 (04) 367-373
• 5 TPMT Nomenclature Committee. TPMT alleles. Accessed May 18, 2020 at: https://www.hmv.liu.se/tpmtalleles/tabell-over-tpmt-alleler?l=en
• 6 Srimartpirom S, Tassaneeyakul W, Kukongviriyapan V, Tassaneeyakul W. Thiopurine S-methyltransferase genetic polymorphism in the Thai population. Br J Clin Pharmacol 2004; 58 (01) 66-70
• 7 McLeod HL, Krynetski EY, Relling MV, Evans WE. Genetic polymorphism of thiopurine methyltransferase and its clinical relevance for childhood acute lymphoblastic leukemia. Leukemia 2000; 14 (04) 567-572
• 8 Song DK, Zhao J, Zhang LR. TPMT genotype and its clinical implication in renal transplant recipients with azathioprine treatment. J Clin Pharm Ther 2006; 31 (06) 627-635
• 9 Moriyama T, Yang YL, Nishii R. et al. Novel variants in NUDT15 and thiopurine intolerance in children with acute lymphoblastic leukemia from diverse ancestry. Blood 2017; 130 (10) 1209-1212
• 10 Cargnin S, Genazzani AA, Canonico PL, Terrazzino S. Diagnostic accuracy of NUDT15 gene variants for thiopurine-induced leukopenia: a systematic review and meta-analysis. Pharmacol Res 2018; 135: 102-111
• 11 Kakuta Y, Kinouchi Y, Shimosegawa T. Pharmacogenetics of thiopurines for inflammatory bowel disease in East Asia: prospects for clinical application of NUDT15 genotyping. J Gastroenterol 2018; 53 (02) 172-180
• 12 Tanaka Y, Kato M, Hasegawa D. et al. Susceptibility to 6-MP toxicity conferred by a NUDT15 variant in Japanese children with acute lymphoblastic leukaemia. Br J Haematol 2015; 171 (01) 109-115
• 13 Tanaka Y, Nakadate H, Kondoh K, Nakamura K, Koh K, Manabe A. Interaction between NUDT15 and ABCC4 variants enhances intolerability of 6-mercaptopurine in Japanese patients with childhood acute lymphoblastic leukemia. Pharmacogenomics J 2018; 18 (02) 275-280
• 14 Yang JJ, Landier W, Yang W. et al. Inherited NUDT15 variant is a genetic determinant of mercaptopurine intolerance in children with acute lymphoblastic leukemia. J Clin Oncol 2015; 33 (11) 1235-1242
• 15 Yang SK, Hong M, Baek J. et al. A common missense variant in NUDT15 confers susceptibility to thiopurine-induced leukopenia. Nat Genet 2014; 46 (09) 1017-1020
• 16 Seksarn P, Wiangnon S, Veerakul G, Chotsampancharoen T, Kanjanapongkul S, Chainansamit SO. Outcome of childhood acute lymphoblastic leukemia treated using the Thai National protocols. Asian Pac J Cancer Prev 2015; 16 (11) 4609-4614
• 17 Thai Pediatric Oncology Group (ThaiPOG). National protocol for the treatment of childhood cancers 2016. Bangkok: M Print Corporation; 2016: 330
• 18 Moradveisi B, Muwakkit S, Zamani F, Ghaderi E, Mohammadi E, Zgheib NK. ITPA, TPMT, and NUDT15 genetic polymorphisms predict 6-mercaptopurine toxicity in Middle Eastern children with acute lymphoblastic leukemia. Front Pharmacol 2019; 10: 916
• 19 Sutiman N, Chen S, Ling KL. et al. Predictive role of NUDT15 variants on thiopurine-induced myelotoxicity in Asian inflammatory bowel disease patients. Pharmacogenomics 2018; 19 (01) 31-43
• 20 Hongeng S, Sasanakul W, Chuansumrit A, Pakakasama S, Chattananon A, Hathirat P. Frequency of thiopurine S-methyltransferase genetic variation in Thai children with acute leukemia. Med Pediatr Oncol 2000; 35 (04) 410-414
• 21 Buaboonnam J, Sripatanatadasakul P, Treesucon A. et al. Effect of NUDT15 on incidence of neutropenia in children with acute lymphoblastic leukemia. Pediatr Int (Roma) 2019; 61 (08) 754-758
• 22 Hon YY, Fessing MY, Pui CH, Relling MV, Krynetski EY, Evans WE. Polymorphism of the thiopurine S-methyltransferase gene in African-Americans. Hum Mol Genet 1999; 8 (02) 371-376
• 23 Zhou H, Li L, Yang P. et al. Optimal predictor for 6-mercaptopurine intolerance in Chinese children with acute lymphoblastic leukemia: NUDT15, TPMT, or ITPA genetic variants?. BMC Cancer 2018; 18 (01) 516
• 24 Liang DC, Yang CP, Liu HC. et al. NUDT15 gene polymorphism related to mercaptopurine intolerance in Taiwan Chinese children with acute lymphoblastic leukemia. Pharmacogenomics J 2016; 16 (06) 536-539
• 25 Tanaka Y, Manabe A, Nakadate H. et al. The activity of the inosine triphosphate pyrophosphatase affects toxicity of 6-mercaptopurine during maintenance therapy for acute lymphoblastic leukemia in Japanese children. Leuk Res 2012; 36 (05) 560-564
• 26 Ando M, Ando Y, Hasegawa Y, Sekido Y, Shimokata K, Horibe K. Genetic polymorphisms of thiopurine S-methyltransferase and 6-mercaptopurine toxicity in Japanese children with acute lymphoblastic leukaemia. Pharmacogenetics 2001; 11 (03) 269-273
• 27 Tanaka Y, Manabe A, Fukushima H. et al. Multidrug resistance protein 4 (MRP4) polymorphisms impact the 6-mercaptopurine dose tolerance during maintenance therapy in Japanese childhood acute lymphoblastic leukemia. Pharmacogenomics J 2015; 15 (04) 380-384
• 28 Park Y, Kim H, Choi JY. et al. Star allele-based haplotyping versus gene-wise variant burden scoring for predicting 6-mercaptopurine intolerance in pediatric acute lymphoblastic leukemia patients. Front Pharmacol 2019; 10: 654
• 29 Choi R, Sohn I, Kim MJ. et al. Pathway genes and metabolites in thiopurine therapy in Korean children with acute lymphoblastic leukaemia. Br J Clin Pharmacol 2019; 85 (07) 1585-1597
• 30 Peregud-Pogorzelski J, Tetera-Rudnicka E, Kurzawski M. et al. Thiopurine S-methyltransferase (TPMT) polymorphisms in children with acute lymphoblastic leukemia, and the need for reduction or cessation of 6-mercaptopurine doses during maintenance therapy: the Polish multicenter analysis. Pediatr Blood Cancer 2011; 57 (04) 578-582
• 31 Chiengthong K, Ittiwut C, Muensri S. et al. NUDT15 c.415C>T increases risk of 6-mercaptopurine induced myelosuppression during maintenance therapy in children with acute lymphoblastic leukemia. Haematologica 2016; 101 (01) e24-e26
• 32 Zhou Y, Wang L, Zhai XY. et al. Precision therapy of 6-mercaptopurine in Chinese children with acute lymphoblastic leukaemia. Br J Clin Pharmacol 2020; 86 (08) 1519-1527
• 33 Tsujimoto S, Osumi T, Uchiyama M. et al. Diplotype analysis of NUDT15 variants and 6-mercaptopurine sensitivity in pediatric lymphoid neoplasms. Leukemia 2018; 32 (12) 2710-2714
• 34 Vannaprasaht S, Angsuthum S, Avihingsanon Y. et al. Impact of the heterozygous TPMT*1/*3C genotype on azathioprine-induced myelosuppression in kidney transplant recipients in Thailand. Clin Ther 2009; 31 (07) 1524-1533
• 35 Chao K, Wang X, Cao Q. et al. Combined detection of NUDT15 variants could highly predict thiopurine-induced leukopenia in Chinese patients with inflammatory bowel disease: a multicenter analysis. Inflamm Bowel Dis 2017; 23 (09) 1592-1599
• 36 Relling MV, Schwab M, Whirl-Carrillo M. et al. Clinical Pharmacogenetics Implementation Consortium guideline for thiopurine dosing based on TPMT and NUDT15 genotypes: 2018 update. Clin Pharmacol Ther 2019; 105 (05) 1095-1105